124 related articles for article (PubMed ID: 22982144)
1. Methylation mediated silencing of miR-23b expression and its role in glioma stem cells.
Geng J; Luo H; Pu Y; Zhou Z; Wu X; Xu W; Yang Z
Neurosci Lett; 2012 Oct; 528(2):185-9. PubMed ID: 22982144
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
Grossi I; Arici B; Portolani N; De Petro G; Salvi A
Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells.
Sun L; Wu Z; Shao Y; Pu Y; Miu W; Yao J; Wu Y; Yang Z
Technol Cancer Res Treat; 2012 Oct; 11(5):483-90. PubMed ID: 22568628
[TBL] [Abstract][Full Text] [Related]
4. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
[TBL] [Abstract][Full Text] [Related]
6. MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.
Jin C; Li M; Ouyang Y; Tan Z; Jiang Y
J Neurooncol; 2017 Jun; 133(2):247-255. PubMed ID: 28508328
[TBL] [Abstract][Full Text] [Related]
7. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.
Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y
BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508
[TBL] [Abstract][Full Text] [Related]
8. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
9. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
11. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
Shi L; Fei X; Wang Z; You Y
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
[TBL] [Abstract][Full Text] [Related]
12. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
[TBL] [Abstract][Full Text] [Related]
13. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
Wang J; Sai K; Chen FR; Chen ZP
Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2.
Zhang D; Jing Z; Qiu B; Wu A; Wang Y
Oncol Rep; 2011 Oct; 26(4):901-8. PubMed ID: 21725605
[TBL] [Abstract][Full Text] [Related]
15. [Overexpressed miRNA-134b inhibits proliferation and invasion of CD133
Liu Y; Zhang B; Wen C; Wen G; Zhou G; Zhang J; He H; Wang N; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):637-642. PubMed ID: 28502302
[TBL] [Abstract][Full Text] [Related]
16. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
Gong X; Schwartz PH; Linskey ME; Bota DA
Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
[TBL] [Abstract][Full Text] [Related]
17. MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation.
Ghasemi A; Fallah S; Ansari M
Clin Lab; 2016; 62(4):573-80. PubMed ID: 27215075
[TBL] [Abstract][Full Text] [Related]
18. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
19. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract][Full Text] [Related]
20. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]